 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (August 2020) |
 | |
 Headquarters in Thousand Oaks, California | |
| Formerly | Applied Molecular Genetics (1980–1983) |
|---|---|
| Company type | Public |
| ISIN | US0311621009 |
| Industry | Biotechnology |
| Founded | April 8, 1980 |
| Headquarters | Thousand Oaks, California, U.S. |
Key people | Robert A. Bradway (chairman, president & CEO) |
| Products | |
| Revenue |  US$28.19 billion (2023) |
 US$7.897 billion (2023) | |
| US$6.717 billion (2023) | |
| Total assets | US$97.15 billion (2023) |
| Total equity | US$6.232 billion (2023) |
Number of employees | c. 26,700 (2023) |
| Website | amgen |
| Footnotes / references [1][2] | |
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.[3][4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.[5]
The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its initial public offering). The company is listed on the Nasdaq Global Select Market under the ticker symbol "AMGN", as well as a component of the Nasdaq-100, the Dow Jones Industrial Average, and the S&P 100 and 500 indices.
- ^ "About Amgen Fact Sheet". amgen.com. Retrieved 9 March 2020.
- ^ "US SEC: 2023 Form 10-K Amgen Inc". U.S. Securities and Exchange Commission. February 14, 2024.
- ^ Amgen History official site page accessed January 2, 2016
- ^ Ronald Vogel. Pharmaceutical Economics and Public Policy. CRC Press, 2007. ISBN 9781439801345. P. 208
- ^ Talhelm, Matt (7 March 2022). "Amgen to offer workers an average salary of $119,510 at new facility". WRAL TechWire. Retrieved 20 September 2022.